Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years' experience. Academic Article uri icon

Overview

abstract

  • Kidney transplantation is the optimal therapy for end-stage kidney disease but limited by the available number of organs. Using HCV+ donors, both in HCV+ and HCV- recipients, is a rational response to the organ shortage. We review the historic experience using HCV+ donors in HCV+ recipients and assess long-term results. We also discuss contemporary practices, including the transplantation of HCV-viremic kidneys into HCV- recipients with different approaches to posttransplant HCV therapy.

publication date

  • December 21, 2022

Identity

Scopus Document Identifier

  • 85144804653

Digital Object Identifier (DOI)

  • 10.1016/j.nefroe.2022.04.006

PubMed ID

  • 36564226